11 Aug, EOD - Indian

Nifty Smallcap 100 17491.7 (0.36)

Nifty Pharma 21604.65 (0.95)

Nifty IT 34544.65 (0.42)

Nifty Next 50 66283.95 (1.17)

SENSEX 80604.08 (0.93)

Nifty Midcap 100 56479 (0.85)

Nifty 50 24585.05 (0.91)

Nifty Bank 55510.75 (0.92)

11 Aug, EOD - Global

NIKKEI 225 42820.49 (2.39)

HANG SENG 24889.81 (-0.07)

S&P 6417.75 (0.09)

LOGIN HERE

flag

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Company History

Patel Chem Specialities Limited was originally incorporated on June 25, 2008 as 'Patel Chem Specialities Private Limited' with the Registrar of Companies, Gujarat. Company converted from a private limited to public limited and the name of the Company changed to 'Patel Chem Specialities Limited' and a fresh Certificate of Incorporation was issued on August 29, 2024, by the Registrar of Companies, CPC.

Since the year 2008, Company manufactures Sodium Monochloro Acetate (SMCA), Sodium Starch Glycolate (SSG), Croscaremellose Sodium (CCS), Carboxymethyl Cellulose Calcium (Calcium CMC), Sodium Carboxymethyl Cellulose (Sodium CMC), Microcrystalline Cellulose (MCC)). Additionally, Sodium Monochloro Acetate (SMCA) is a key raw material for our products and has applications in drug production and nutritional products. The manufacturing plants are functional in Vatva, Ahmedabad, and Talod, Himmatnagar.

Company operates in the field of specialty chemicals, particularly focusing on the production of cellulose-based excipients, which find application in Pharmaceutical, Food & Beverages, Cosmetics and other industries. These chemicals are fundamental in the formulation of essential products such as tablets, food additives, personal care items, and industrial formulations. The products play vital roles as binders, disintegrants, thickeners, stabilizers, and gelling agents, each serving a specialized function across multiple sectors.

Company launched the Initial Public Offer of 70,00,000 Equity Shares of face value of Rs 10 by raising Rs 58.8 Cr thru' fresh issue in July, 2025.

Vatva Unit has been registered as US-FDA approved facility in FY 2025.

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +